GetTopicDetailResponse(id=1955118410b, topicName=miR-185, introduction=miR-185, content=null, image=null, comments=3, allHits=1141, url=https://h5.medsci.cn/topic?id=11841, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=71407, tagList=[TagDto(tagId=71407, tagName=miR-185)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1755628, encodeId=5b171e5562837, content=<a href='/topic/show?id=1955118410b' target=_blank style='color:#2F92EE;'>#miR-185#</a>, objectTitle=?？颂婺崤c安羅替尼治療晚期非小細(xì)胞肺癌療效比較及對miR-185-5p、miR-204-5p表達(dá)水平影響觀察, objectType=article, longId=220671, objectId=e6e52206e1f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6e52206e1f8, replyNumber=0, likeNumber=104, createdTime=2021-12-06, rootId=0, userName=HNYYM, userId=477f36977759, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6e52206e1f8, moduleTitle=埃克替尼與安羅替尼治療晚期非小細(xì)胞肺癌療效比較及對miR-185-5p、miR-204-5p表達(dá)水平影響觀察, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e6e52206e1f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755627, encodeId=35901e556275e, content=<a href='/topic/show?id=1955118410b' target=_blank style='color:#2F92EE;'>#miR-185#</a>, objectTitle=Blood：miR-185/PAK6軸調(diào)控CML耐藥性白血病干細(xì)胞的存活，可預(yù)測治療反應(yīng)性, objectType=article, longId=192492, objectId=9f3f19249258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f3f19249258, replyNumber=0, likeNumber=79, createdTime=2020-06-18, rootId=0, userName=HNYYM, userId=477f36977759, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f3f19249258, moduleTitle=Blood：miR-185/PAK6軸調(diào)控CML耐藥性白血病干細(xì)胞的存活，可預(yù)測治療反應(yīng)性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9f3f19249258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755626, encodeId=0f191e55626f7, content=<a href='/topic/show?id=1955118410b' target=_blank style='color:#2F92EE;'>#miR-185#</a>, objectTitle=Mol Ther Nucleic Acids：miR-185抑制肝星狀細(xì)胞激活和纖維化進(jìn)展, objectType=article, longId=132043, objectId=544f13204328, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=544f13204328, replyNumber=0, likeNumber=81, createdTime=2018-10-02, rootId=0, userName=HNYYM, userId=477f36977759, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=544f13204328, moduleTitle=Mol Ther Nucleic Acids：miR-185抑制肝星狀細(xì)胞激活和纖維化進(jìn)展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=544f13204328)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
